About this episode

The episode discusses key developments in lung cancer from the 2026 BTOG conference.

In this week’s VJOncology podcast, we had the opportunity to attend the 2026 British Thoracic Oncology Group (BTOG) conference, where we explored key developments in lung cancer screening, diagnostics, and clinical research. Join Robert Rintoul, University of Cambridge, Cambridge, UK, Lauren Dixon, London School of Hygiene & Tropical Medicine, London, UK, Mariana Brandao, Jules Bordet Institute, Brussels, Belgium, and Anna Bibby, North Bristol NHS Trust, Bristol, UK as they discuss national screening updates, insights from the State of the Nation report, ongoing EORTC trials, and the clinical implications of incidental findings in lung cancer screening programs.

More episodes of VJOncology Podcast

• Bladder Cancer Awareness Month: subtypes, diagnostics & breakthroughs · May 8, 2026 · 16 min
• Beyond EGFR: navigating molecular targets and emerging therapies in advanced NSCLC · April 30, 2026 · 17 min
• Head and neck cancer awareness month: key trials and evolving treatment strategies · April 17, 2026 · 14 min
• Immuno-oncology updates from 12th Immunotherapy of Cancer Conference · March 20, 2026 · 13 min
• Top updates from ASCO GU 2026: latest trials in prostate, kidney, and bladder cancer · March 6, 2026 · 18 min
• Esophageal cancer awareness month: from multidisciplinary dialogue to clinical impact · February 20, 2026 · 17 min

Explore listener stats, chart rankings, contacts and more on the VJOncology Podcast podcast page.